Taken together, our results suggest that miR-23a partially promotes pancreatic cancer EMT and metastasis by targeting ESRP1 and regulating CD44 splicing as well as FGFR2 IIIb and FGFR2 IIIc mRNA levels (Figure 10E). Here, ESRP1 is linked to familial pancreatic carcinoma.